
The Hang Seng Index climbed about one point eight per cent to around twenty-seven thousand seventy-four, while the Hang Seng Tech sub-index also advanced, reflecting broad optimism among traders.
The offshore yuan’s offshore spot rate strengthened to about six point ninety-seven against the dollar, its highest level since May two thousand twenty-three, easing some currency pressure and lifting sentiment toward China-linked assets.
Chinese pharmaceutical and healthcare stocks led the gains, with major players such as WuXi AppTec, Wuxi Biologics and Alibaba Health Information Technology posting notable increases in share prices as investors rotated into health and biotech themes.
Not all sectors saw uniform gains, with certain consumer and leisure names, including instant noodle maker Tingyi Cayman Islands Holding and entertainment-oriented toymaker Pop Mart, trading lower amid selective profit-taking.
Mainland Chinese indexes showed mixed performance, with the CSI three hundred modestly higher while the Shanghai Composite dipped slightly as markets digested macro signals.
Analysts noted that the strong yuan contributed to the positive tone, with a softer U.S. dollar and shifts in global investor focus beyond U.S. markets helping underpin regional equity advances into the early trading session, even as geopolitical uncertainties persist.










































